Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.65% | 36.49 | 0.9% | $1153.00m | |
| JNJ | Johnson & Johnson | -0.25% | 162.37 | 0.7% | $1102.47m | |
| LLY | Eli Lilly & Co. | 1.34% | 201.14 | 1.1% | $797.96m | |
| ABBV | AbbVie, Inc. | 0.39% | 112.62 | 1.9% | $726.43m | |
| MRK | Merck & Co., Inc. | -0.89% | 82.45 | 0.7% | $676.18m | |
| BMY | Bristol-Myers Squibb Co. | -0.72% | 66.26 | 1.0% | $666.15m | |
| AZN | AstraZeneca Plc | -0.63% | 52.24 | 1.2% | $646.37m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | -1.68% | 67.30 | 0.0% | $228.97m | |
| VTRS | Viatris, Inc. | 1.43% | 17.69 | 0.0% | $194.67m | |
| GRTS | Gritstone Oncology, Inc. | 14.46% | 25.49 | 0.0% | $175.56m | |
| RPRX | Royalty Pharma Plc | -2.89% | 50.35 | 0.2% | $171.53m | |
| NVS | Novartis AG | 0.25% | 96.93 | 0.2% | $167.79m | |
| GSK | GlaxoSmithKline Plc | -1.35% | 38.02 | 0.2% | $146.69m | |
| SNY | Sanofi | -1.19% | 49.91 | 0.2% | $118.17m | |
| RGEN | Repligen Corp. | -2.48% | 216.67 | 6.9% | $80.89m |
Company Profile
Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, KPL-716, KPL-045, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Hamilton, Bermuda.